我武生物
(300357)
| 流通市值：115.22亿 | | | 总市值：124.67亿 |
| 流通股本：4.84亿 | | | 总股本：5.24亿 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 252,840,950.04 | 1,062,404,471.43 | 853,360,357.81 | 484,236,510.36 |
| 营业收入 | 252,840,950.04 | 1,062,404,471.43 | 853,360,357.81 | 484,236,510.36 |
| 二、营业总成本 | 149,929,001.8 | 635,510,347.27 | 459,695,071.95 | 288,042,152.3 |
| 营业成本 | 12,021,601.28 | 50,582,171.21 | 39,475,057.42 | 23,722,425.65 |
| 税金及附加 | 362,195.73 | 11,560,988.02 | 5,096,763.82 | 3,685,992.89 |
| 销售费用 | 95,348,070.74 | 397,842,380.84 | 291,557,577.22 | 178,121,714.43 |
| 管理费用 | 21,737,745.42 | 81,262,692.08 | 58,760,176.47 | 37,671,306.59 |
| 研发费用 | 24,912,558.24 | 117,102,467.92 | 85,698,742.52 | 58,829,519.3 |
| 财务费用 | -4,453,169.61 | -22,840,352.8 | -20,893,245.5 | -13,988,806.56 |
| 其中:利息费用 | 233,077.05 | 792,851.32 | 596,368.52 | 406,344.87 |
| 其中:利息收入 | 4,710,727.62 | 23,724,510.41 | 21,562,143.29 | 14,439,586.38 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 1,746,318.99 | 3,425,972.25 | 1,629,261.04 | 1,328,169.78 |
| 加:投资收益 | 29,682,739.53 | 2,721,381.62 | 212,085.8 | 16,143.8 |
| 资产处置收益 | - | 630,073.33 | 630,073.33 | 630,073.33 |
| 资产减值损失(新) | - | -4,768,382.16 | - | - |
| 信用减值损失(新) | -4,232,680.59 | -843,065.04 | -6,005,806.45 | -2,207,917.71 |
| 其他收益 | 2,984,743.78 | 10,357,356.85 | 7,566,395.89 | 5,400,152.83 |
| 四、营业利润 | 133,093,069.95 | 438,417,461.01 | 397,697,295.47 | 201,360,980.09 |
| 加:营业外收入 | 359,377.55 | 174,714.09 | 91,860.98 | 91,358.37 |
| 减:营业外支出 | 1,669,140.86 | 5,886,800.1 | 3,510,803.68 | 1,923,245.66 |
| 五、利润总额 | 131,783,306.64 | 432,705,375 | 394,278,352.77 | 199,529,092.8 |
| 减:所得税费用 | 15,270,671.79 | 64,616,129.11 | 59,041,362.8 | 29,099,866.47 |
| 六、净利润 | 116,512,634.85 | 368,089,245.89 | 335,236,989.97 | 170,429,226.33 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 116,512,634.85 | 368,089,245.89 | 335,236,989.97 | 170,429,226.33 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 119,232,154.49 | 380,940,984.34 | 344,866,533.27 | 177,008,721.63 |
| 少数股东损益 | -2,719,519.64 | -12,851,738.45 | -9,629,543.3 | -6,579,495.3 |
| 扣除非经常损益后的净利润 | 89,346,226.01 | 374,199,121.5 | 340,017,792.25 | 172,590,977.7 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.23 | 0.73 | 0.66 | 0.34 |
| (二)稀释每股收益 | 0.23 | 0.73 | 0.66 | 0.34 |
| 八、其他综合收益 | -6,064.56 | -6,986.28 | -4,046.55 | -4,365.07 |
| 归属于母公司股东的其他综合收益 | -6,064.56 | -6,986.28 | -4,046.55 | -4,365.07 |
| 九、综合收益总额 | 116,506,570.29 | 368,082,259.61 | 335,232,943.42 | 170,424,861.26 |
| 归属于母公司股东的综合收益总额 | 119,226,089.93 | 380,933,998.06 | 344,862,486.72 | 177,004,356.56 |
| 归属于少数股东的综合收益总额 | -2,719,519.64 | -12,851,738.45 | -9,629,543.3 | -6,579,495.3 |
| 公告日期 | 2026-04-24 | 2026-04-24 | 2025-10-24 | 2025-08-22 |
| 审计意见(境内) | | 标准无保留意见 | | |